Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.5B |
| 2 |
Apple
AAPL
|
+$1.68B |
| 3 |
Tesla
TSLA
|
+$951M |
| 4 |
Johnson & Johnson
JNJ
|
+$750M |
| 5 |
UnitedHealth
UNH
|
+$703M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CTXS
Citrix Systems Inc
CTXS
|
+$913M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$257M |
| 3 |
NVIDIA
NVDA
|
+$225M |
| 4 |
Vertiv
VRT
|
+$164M |
| 5 |
JPMorgan Chase
JPM
|
+$161M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.48% |
| 2 | Healthcare | 7.36% |
| 3 | Financials | 6.5% |
| 4 | Consumer Discretionary | 5.35% |
| 5 | Industrials | 3.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3326
PUT
Canadian Natural Resources
CNQ
$96.6B
| $422K | ﹤0.01% |
+15,200
| New | +$434K |
|
|
EH
3327
EHang Holdings
EH
$414M
| $422K | ﹤0.01% |
49,134
| – | – |
|
|
BRY
3328
DELISTED
Berry Corp
BRY
| $420K | ﹤0.01% |
52,515
+43,554
| +486% | +$373K |
|
3329
Kelly Services Class A
KELYA
$522M
| $419K | ﹤0.01% |
24,811
+7,186
| +41% | +$115K |
|
|
HRT
3330
DELISTED
HireRight Holdings Corporation
HRT
| $418K | ﹤0.01% |
35,242
+14,245
| +68% | +$177K |
|
|
AGR
3331
DELISTED
Avangrid, Inc.
AGR
| $417K | ﹤0.01% |
9,706
-52,036
| -84% | -$2.16M |
|
3332
Wells Fargo 7.5% Non Cumv Perp Conv
WFC.PRL
$4.69B
| $415K | ﹤0.01% |
+350
| New | +$416K |
|
3333
ZipRecruiter
ZIP
$360M
| $414K | ﹤0.01% |
25,229
+11,079
| +78% | +$184K |
|
|
MNTV
3334
DELISTED
Momentive Global Inc. Common Stock
MNTV
| $412K | ﹤0.01% |
58,921
-489
| -0.8% | -$3.53K |
|
3335
PDF Solutions
PDFS
$2.16B
| $411K | ﹤0.01% |
14,427
+6,303
| +78% | +$170K |
|
|
RIDE
3336
DELISTED
Lordstown Motors Corp. Class A Common Stock
RIDE
| $411K | ﹤0.01% |
24,043
+2,747
| +13% | +$63.8K |
|
|
BWIN
3337
Baldwin Insurance Group
BWIN
$2.72B
| $410K | ﹤0.01% |
16,323
+13,795
| +546% | +$380K |
|
|
DICE
3338
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
| $410K | ﹤0.01% |
13,137
+7,181
| +121% | +$234K |
|
3339
RXO
RXO
$3.56B
| $409K | ﹤0.01% |
+23,777
| New | +$422K |
|
3340
CALL
Signet Jewelers
SIG
$3.75B
| $408K | ﹤0.01% |
+6,000
| New | +$382K |
|
3341
Offerpad Solutions
OPAD
$22.2M
| $408K | ﹤0.01% |
5,903
+103
| +2% | +$11.9K |
|
3342
Mesa Laboratories
MLAB
$568M
| $407K | ﹤0.01% |
2,450
+1,145
| +88% | +$179K |
|
|
NVO
3343
Novo Nordisk
NVO
$195B
| $406K | ﹤0.01% |
6,000
| – | – |
|
3344
Agilon Health
AGL
$1.5B
| $405K | ﹤0.01% |
1,004
-2,594
| -72% | -$1.22M |
|
|
HSKA
3345
DELISTED
Heska Corp
HSKA
| $404K | ﹤0.01% |
6,507
+1,740
| +37% | +$117K |
|
3346
Gogo Inc
GOGO
$633M
| $404K | ﹤0.01% |
27,346
+7,657
| +39% | +$111K |
|
3347
IAMGOLD
IAG
$8.59B
| $403K | ﹤0.01% |
156,260
+34,300
| +28% | +$59.6K |
|
3348
Arhaus
ARHS
$1.17B
| $403K | ﹤0.01% |
+41,300
| New | +$360K |
|
3349
Pricesmart
PSMT
$6.05B
| $402K | ﹤0.01% |
6,608
+4,865
| +279% | +$317K |
|
3350
Hertz
HTZ
$489M
| $401K | ﹤0.01% |
26,071
-28,833
| -53% | -$486K |
|
Similar funds
Barclays's Q4 2022 Portfolio in Review
As of Q4 2022, Barclays held 5,646 positions worth $223B, up 144% from $91.6B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Barclays deployed $128B of net new capital in Q4 2022, opening 798 new positions and adding to 2,634 existing holdings. Its largest new stake was Seadrill: 1,546,558 shares worth $50.5M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $257M trimmed.
- Barclays's largest Q4 2022 buy was Seadrill: 1,546,558 shares worth $50.5M.
- Barclays added most to Microsoft in Q4 2022, an estimated $2.5B increase.
- Barclays's biggest Q4 2022 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $257M.
- Barclays fully exited Citrix Systems Inc in Q4 2022, selling an estimated $913M.
- Barclays's ten largest holdings make up 41% of its $223B portfolio in Q4 2022.
- Barclays opened 798 new positions and closed 385 in Q4 2022.
- Barclays's portfolio value rose 144% quarter-over-quarter to $223B.
Based on Barclays's 13F filing for Q4 2022, filed 13 Feb 2023.